Technology, Science, & Me!: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology, Science, & Me!.

Press releases published on October 5, 2026

Oct. 5, 2026

Duos Technologies Sells Its GPU-as-a-Service Entity to Axe Compute, Accelerating Its Shift to a Pure-Play AI Colocation Platform

Indeterminate GlobeNewswire

Oct. 5, 2026

Aprea Therapeutics to Present at October Conferences

Indeterminate GlobeNewswire

Oct. 5, 2026

Axe Compute Takes Full Ownership of Georgia AI Cluster, Significantly Increasing the Contract’s Expected Free Cash Flow and Gross Margin

Indeterminate GlobeNewswire

Oct. 5, 2026

Navitas and Microchip Collaborate to Deliver 800V Reference Design for Next-Generation AI Data Centers

Indeterminate GlobeNewswire

Oct. 5, 2026

Autolus Therapeutics to Present Longer-Term Follow Up Data from CARLYSLE Trial at the American College of Rheumatology Convergence 2026

Indeterminate GlobeNewswire

Oct. 5, 2026

IES Holdings Completes Acquisition of DBM Global

Indeterminate GlobeNewswire

Oct. 5, 2026

SAIC Acquires Information Security Corporation, Expanding Zero-Trust, Post-Quantum Cryptography and Encryption Capability

Indeterminate GlobeNewswire

Oct. 5, 2026

Zorronet Ltd. Announces Joint Framework Agreement with Tier 1 Israeli IT Integrator

Indeterminate GlobeNewswire

Oct. 5, 2026

Wood Mackenzie connects trusted energy intelligence with Microsoft Copilot

Indeterminate GlobeNewswire

Oct. 5, 2026

Music Industry Community Brings Music, Networking, and Industry Connections to Chase Bell and LIRA’s “Do Me” Live Experience

Indeterminate GlobeNewswire

Oct. 5, 2026

Coverys Reveals 68% of Inpatient Diagnostic Errors Occur on General Medical-Surgical Units

Indeterminate GlobeNewswire

Oct. 5, 2026

Z-TEXT zk-SNARKs Messenger Opens to the Public: No Phone, No SIM

Indeterminate EIN Presswire

Oct. 5, 2026

HIGHCOURT Announces Expanded Legal Knowledge and MKC2 Review Capabilities

Indeterminate EIN Presswire

Oct. 5, 2026

Radiopharm Completes Productive End-of-Phase 2 Meeting with U.S. Food and Drug Administration for Pivotal Development Program of RAD101

Indeterminate GlobeNewswire

Oct. 5, 2026

STMicroelectronics announces status of common share repurchase program

Indeterminate GlobeNewswire

Oct. 5, 2026

ASML reports transactions under its current share buyback program

Indeterminate GlobeNewswire

Oct. 5, 2026

Orion Pharma announces first patient dosed in Phase 1/2 clinical trial of ODM-216, the company’s first biologic candidate to reach clinical testing

Indeterminate GlobeNewswire

Oct. 5, 2026

Ensimmäinen potilas on saanut hoitoa Orion Pharman Faasi 1/2 -tutkimuksessa ODM-216-molekyylillä, joka on yhtiön ensimmäinen kliiniseen kehitysvaiheeseen edennyt biologinen syöpälääkeaihio

Indeterminate GlobeNewswire

Oct. 5, 2026

BEYYON Rechargeable Hand Warmers with LED Displays: Two Market-Tested Cold-Weather Essentials, Each in a 2-Pack

Indeterminate GlobeNewswire

Oct. 5, 2026

PDAOAI Opens BIO REBOOT Collaboration and Showcases Partitioned Literature Aggregation at Drug Discovery 2026

Indeterminate GlobeNewswire